Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: 2020-08-25

DOI: 10.1073/pnas.2004281117

Affiliations: 12

Authors: 22

Institutions	Authors	Share
Oxford Kennedy Institute of Rheumatology, United Kingdom (UK)		0.32
Oxford Wellcome Trust Centre for Human Genetics, United Kingdom (UK)		0.14
Celgene Corporation, United States of America (USA)		0.09
Oxford Target Discovery Institute (TDI), United Kingdom (UK)		0.09
NIHR Oxford Biomedical Research Centre (OxBRC), United Kingdom (UK)		0.05
Radboud University Medical Centre (Radboudumc), RU, Netherlands		0.05
Broomfield Hospital, Mid Essex Hospital Services NHS Trust, United Kingdom (UK)		0.05
Royal Derby Hospital, United Kingdom (UK)		0.05
University Hospital Southampton NHS Foundation Trust, United Kingdom (UK)		0.05
Queen Victoria Hospital National Health Service Foundation Trust, United Kingdom (UK)		0.05
St John's Hospital, NHS Lothian, United Kingdom (UK)		0.05
Structural Genomics Consortium (SGC Karolinska), Sweden		0.05

Return

Latest supplement

Nature Index 2021 Asia Pacific

Sustainability, climate-change mitigation, and biomedical science are key areas for future research prowess in the Asia-Pacific region. While COVID-19 travel restrictions have disrupted collaborations between far-flung nations, they have focused attention on vast opportunities for researchers in countries in close proximity and South and southeast Asia to work more closely together on new initiatives.

Access free